Valuation: Hologic, Inc.

Capitalization 13.1B 11.49B 10.78B 9.77B 18.13B 1,115B 20.49B 126B 49.08B 504B 49.12B 48.1B 1,862B P/E ratio 2025 *
16.8x
P/E ratio 2026 * 15.1x
Enterprise value 13.03B 11.43B 10.73B 9.72B 18.04B 1,109B 20.39B 125B 48.83B 501B 48.88B 47.86B 1,853B EV / Sales 2025 *
3.19x
EV / Sales 2026 * 2.85x
Free-Float
74.01%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.48%
1 week+0.29%
Current month-5.52%
1 month-4.83%
3 months-18.27%
6 months-27.80%
Current year-19.05%
More quotes
1 week 57.28
Extreme 57.28
58.6
1 month 55.89
Extreme 55.89
63
Current year 55.89
Extreme 55.89
74.5
1 year 55.89
Extreme 55.89
84.67
3 years 55.89
Extreme 55.89
87.88
5 years 48.39
Extreme 48.39
87.88
10 years 26.49
Extreme 26.49
87.88
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 2013-12-06
Director of Finance/CFO 55 2018-07-31
Chief Operating Officer 45 2023-12-31
Director TitleAgeSince
Director/Board Member 54 2011-10-31
Chairman 61 2015-06-15
Director/Board Member 70 2017-05-14
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.48%+0.29%-23.84%-18.93% 13.1B
+0.17%+7.55%+37.62%+115.17% 185B
+1.47%-1.66%-25.89%-22.68% 161B
+0.55%+8.09%+41.71%+143.98% 152B
+1.54%+3.57%-19.40%-20.79% 142B
-0.76%+4.64%-11.15%-8.58% 59.64B
+0.98%+8.05%-11.25%-27.89% 44.68B
+0.49%-1.71%-28.55%-30.93% 35.91B
+1.54%+11.05%+9.46%+18.89% 34.86B
+0.03%+10.45%-23.44% - 31.17B
Average +0.74%+5.48%-5.47%+16.47% 85.96B
Weighted average by Cap. +0.79%+5.32%+3.99%+41.11%
See all sector performances

Financials

2025 *2026 *
Net sales 4.08B 3.58B 3.36B 3.05B 5.65B 348B 6.39B 39.28B 15.3B 157B 15.32B 15B 581B 4.3B 3.77B 3.54B 3.21B 5.96B 366B 6.73B 41.39B 16.13B 165B 16.14B 15.81B 612B
Net income 803M 705M 662M 599M 1.11B 68.38B 1.26B 7.73B 3.01B 30.89B 3.01B 2.95B 114B 883M 775M 727M 659M 1.22B 75.18B 1.38B 8.5B 3.31B 33.96B 3.31B 3.24B 126B
Net Debt -66.18M -58.06M -54.5M -49.38M -91.65M -5.63B -104M -637M -248M -2.54B -248M -243M -9.41B -831M -729M -685M -620M -1.15B -70.76B -1.3B -8B -3.12B -31.97B -3.12B -3.05B -118B
More financial data * Estimated data
Logo Hologic, Inc.
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostics (44.2%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin; - breast health (37.8%): digital mammography and breast biopsy solutions and systems; - gynecological surgery (15.9%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures; - bone health (2.1%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment. Net sales break down by source of revenue between sales of products (80.8%) and services (19.2%). Net sales are distributed geographically as follows: the United States (75%), Europe (13.2%), Asia-Pacific (6.5%) and others (5.3%).
Employees
7,063
More about the company
Date Price Change Volume
25-04-29 58.36 $ +0.48% 1,552,012
25-04-28 58.08 $ +0.10% 1,579,271
25-04-25 58.02 $ -0.46% 1,814,362
25-04-24 58.29 $ +0.24% 2,254,509
25-04-23 58.15 $ -0.07% 2,387,437

Delayed Quote Nasdaq, April 29, 2025 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
58.36USD
Average target price
75.40USD
Spread / Average Target
+29.20%
Consensus

Quarterly revenue - Rate of surprise